Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9.

Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9.
复制标题

DOI:
10.1016/j.stem.2014.10.004
复制
发表时间:
2014-11-06
期刊:
影响因子:
23.9
通讯作者:
Cowan, Chad A.
Cowan, Chad A.
中科院分区:
医学1区
文献类型:
--
作者:
Mandal, Pankaj K.;Ferreira, Leonardo M. R.;Collins, Ryan;Meissner, Torsten B.;Boutwell, Christian L.;Friesen, Max;Vrbanac, Vladimir;Garrison, Brian S.;Stortchevoi, Alexei;Bryder, David;Musunuru, Kiran;Brand, Harrison;Tager, Andrew M.;Allen, Todd M.;Talkowski, Michael E.;Rossi, Derrick J.;Cowan, Chad A.

文献摘要

参考文献

被引文献

相似文献

通过CRISPR/Cas9进行基因组编辑凭借其有效性和易用性迅速成为首选工具。然而,CRISPR/Cas9介导的基因组编辑在临床相关的人体细胞中仍然未经测试。在这里,我们报告了CRISPR/Cas9在原代人CD 4 + T细胞和CD 34+造血干细胞和祖细胞(HSPC)中靶向两种临床相关基因B2 M和CCR 5的情况。使用单一RNA指导物导致HSPC中而不是T细胞中的高效诱变。双指导方法改善了两种细胞类型中的基因缺失功效。经过CRISPR/Cas9基因组编辑的HSPC保留了多谱系潜力。我们通过HSPC中的靶捕获测序检查了预测的在靶和脱靶突变,并仅在一个位点观察到低水平的脱靶突变。这些结果表明,CRISPR/Cas9可以以最小的脱靶诱变有效地消除HSPC中的基因,这可能对基于造血细胞的治疗具有广泛的适用性。
Genome editing via CRISPR/Cas9 has rapidly become the tool of choice by virtue of its efficacy and ease of use. However, CRISPR/Cas9 mediated genome editing in clinically relevant human somatic cells remains untested. Here, we report CRISPR/Cas9 targeting of two clinically relevant genes, B2M and CCR5, in primary human CD4+ T cells and CD34+ hematopoietic stem and progenitor cells (HSPCs). Use of single RNA guides led to highly efficient mutagenesis in HSPCs but not in T cells. A dual guide approach improved gene deletion efficacy in both cell types. HSPCs that had undergone genome editing with CRISPR/Cas9 retained multi-lineage potential. We examined predicted on- and off-target mutations via target capture sequencing in HSPCs and observed low levels of off-target mutagenesis at only one site. These results demonstrate that CRISPR/Cas9 can efficiently ablate genes in HSPCs with minimal off-target mutagenesis, which could have broad applicability for hematopoietic cell-based therapy.
DOI: 10.1101/gr.162339.113
发表时间: 2014-01
期刊: Genome research
影响因子: 7
作者:
Cho SW;Kim S;Kim Y;Kweon J;Kim HS;Bae S;Kim JS
通讯作者: Kim JS
DOI: 10.1038/nbt.2808
发表时间: 2014-03
影响因子: 46.9
作者:
通讯作者: --
DOI: 10.1016/j.tibtech.2013.04.004
发表时间: 2013-07
影响因子: 17.3
作者:
Gaj, Thomas;Gersbach, Charles A.;Barbas, Carlos F., III
通讯作者: Barbas, Carlos F., III
DOI: 10.1126/science.1225829
发表时间: 2012-08-17
期刊: SCIENCE
影响因子: 56.9
作者:
Jinek, Martin;Chylinski, Krzysztof;Charpentier, Emmanuelle
通讯作者: Charpentier, Emmanuelle
DOI: 10.1016/j.cell.2014.01.027
发表时间: 2014-02-13
期刊: CELL
影响因子: 64.5
作者:
Niu, Yuyu;Shen, Bin;Sha, Jiahao
通讯作者: Sha, Jiahao